SHL Medical opens new US$220 million manufacturing facility in the US to serve growing autoinjector market
mehr
Storys zum Thema Pharmakologie
-
Sprache:
Englisch
- Medien:
- Zeitraum:
- Zeitraum:Gesamt
SGLT2 HYPE: New EU-funded Project Aims to Transform Hypertension Treatment
mehr- 3
Press Release STADA’s growth journey continues in 2024 - Significant increase in sales and profits - Growing ahead of the market
Ein Dokumentmehr LTS Lohmann Therapie-Systeme AG
LTS wins funding from BARDA’s Patch Forward Prize Competition for two partnerships
mehrSCP-Nano: A New Technology to Visualize Nanocarriers in Cells and Tissues
mehrGrünenthal appoints Prof. Dr. Uli Brödl as Chief Scientific Officer
mehr
RHEACELL receives EMA approval for allo-APZ2-CVU Phase 3 trial in chronic venous ulcers
mehrGerresheimer: FDA grants Tentative Approval of SQ Innovation’s Lasix® ONYU*
mehrStrides Pharma International AG
Strides Pharma Consolidates European Business-to-Business Operations in Switzerland
mehrInceptor Regulates Insulin Homeostasis: A New Approach for Diabetes Therapies
mehr- 2
SHL Medical announces plans to establish SHL Advantec
mehr Event Announcement: VIROFIGHT Hybrid Symposium
Ein Dokumentmehr
RHEACELL announces FDA approval for Phase 3 study in refractory, non-curable CVU
mehr- 2
Fundació Puigvert validates a new tool capable of selecting the most suitable antibiotic for uncomplicated urinary tract infections within 45 minutes.
Ein Dokumentmehr - 2
Record financing rounds at the Munich biotech hub
Ein Dokumentmehr Press release: STADA continues strong growth journey in the first half of 2024
Ein Dokumentmehr- 2
Grünenthal announces significant investments in its Latin America production sites, further securing reliable medicine supply for patients
mehr - 10
Gerresheimer: New pictures available
mehr
canSERV invites applications for "Revolutionising Cancer Patient Care"
Ein Dokumentmehr- 3
canSERV invites applications for "Revolutionising Cancer Patient Care"
Ein Dokumentmehr - 2
Gerresheimer partners with RxCap to offer connected adherence solutions
mehr Dr. Reddy's subsidiary betapharm, and Theranica launch Nerivio® in Germany to provide patients with drug-free migraine treatment
mehrPress release: STADA continues with double-digit sales and profit growth in 2023
Ein DokumentmehrResearch Success in Rare Disease / RHEACELL receives positive signal for accelerated stem cell development program in rare ‚Butterfly Disease‘
mehr
LTS Lohmann Therapie-Systeme AG
First product based on LTS’ Sorrel(TM) wearable drug delivery platform launched in the US
mehrRising Focus on 'Inceptor' as a Type 2 Diabetes Therapeutic Target
mehrTherapeutic Vaccine for Chronic Hepatitis B Enters Clinical Trial
mehrBiomay Announces its Successful Support of Approval of First CRISPR/Cas9-based Therapy
mehrSHL Medical partners with SteriPack Group to set up final assembly service
mehrPress release: Zuellig Pharma becomes STADA Philippines’ exclusive distribution partner
Ein Dokumentmehr
123Nächste